- TICAGRELOR
[作者:Davies, SL,期刊:Drugs of today, 页码:243-250 , 文章类型: Article,,卷期:2010年46-4]
- Coronary artery disease (CAD) is the single leading cause of death in the U.S. Therapies for CAD have been developed to inhibit platelet aggregation underlying atherogenesis. Clinical benefit has been shown with antagoni...
- RECENT ADVANCES IN ADJUNCTIVE THERAPY FOR EPILEPSY: FOCUS ON SODIUM CHANNEL BLOCKERS AS THIRD-GENERATION ANTIEPILEPTIC DRUGS
[作者:Vohora, D; Saraogi, P; Yazdani, MA; Bhowmik, M; Khanam, R; Pillai, KK,期刊:Drugs of today, 页码:265-277 , 文章类型: Review,,卷期:2010年46-4]
- Voltage-gated sodium channel blockers like phenytoin and carbamazepine have long been used in the treatment of epilepsy Brain sodium channels continue to be an important target of many newer second-generation (fosphenyto...
- CONTENTIOUS CONTROVERSIES: A REPORT FROM THE 3(RD) WORLD CONGRESS ON CONTROVERSIES IN UROLOGY (FEBRUARY 25-28, 2010, ATHENS, GREECE)
[作者:Rabasseda, X,期刊:Drugs of today, 页码:291-296 , 文章类型: Article,,卷期:2010年46-4]
- The 3(rd) World Congress on Controversies in Urology held in Athens earlier this year offered a renewed opportunity to discuss many divisive issues in urology, most notably urinary incontinence and prostate cancer, which...
|